- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06875869
Ischemic Compression Technique Versus Jones Technique in Cervicogenic Headache Patients
Comparative Effects of Jones and Ischemic Compression Technique on Pain, Range of Motion and Disability in Patients With Cervicogenic Headache
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cervicogenic headache (CGH) is a secondary headache caused by a disorder of the cervical spine and its disc or bony and/or periarticular components and is often accompanied by neck pain The prevalence cervicogenic headache of in the general population has been reported to be 2.2%-4.1% and appears to predominate in women four times more than in men. Noninvasive treatment techniques consist mainly of electrotherapy, manual therapy (MT), and exercise prescription. Myofascial Trigger Point (MTrP) activity is one of the leading causes of CGH. Jones technique and Ischemic compression ( IC) are two treatment options for trigger points. Cervicogenic headaches are a growing problem impacting daily life, research on cervicogenic headaches is crucial to understand the link between neck issues and headaches, and develop more effective long-term treatment options. In view of the above, the current study aims to evaluate the effectiveness of Physiotherapy interventions i.e. Jones and Ischemic compression technique for Myofascial Trigger Points (MTrPs) of Sternocleidomastoid and upper Trapezius in treating cervicogenic headache.
The current study will help us in determining whether use of these techniques has any significant advantage over conventional treatment for pan and disability in CGH patients. Understanding the most effective therapeutic approach can guide practitioners in selecting evidence-based interventions, ultimately improving the overall well-being of patients suffering from cervicogenic headache.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: imran amjad, PhD*
- Phone Number: 03324390125
- Email: imran.amjad@riphah.edu.pk
Study Contact Backup
- Name: Imran Amjad, PHD*
- Phone Number: 0515481826
- Email: imran.amjad@riphah.edu.pk
Study Locations
-
-
Punjab
-
Bahawalpur, Punjab, Pakistan
- Recruiting
- Bahaval Victoria Hospital
-
Contact:
- Ghulam Fatima, PhD*
- Phone Number: 03034073057
- Email: ghulam.fatima@riphah.edu.pk
-
Principal Investigator:
- Fatima Ashraf, MS*
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Both males and females
- 25-35 years of age
- Individuals satisfying the Cervicogenic Headache criteria
- Positive Simon's criteria for trigger points
Exclusion Criteria:
- primary headaches (i.e., migraine, tension type headache)
- bilateral headache
- Presence of any red flags
- cervical spinal stenosis
- evidence of central nervous system involvement
- prior surgery to the head or neck
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group-A (Jones technique)
Patients will receive Jones technique for the Sternocleidomastoid and upper fibers of Trapezius.
|
In the Jones technique, pressure will be applied on the tender point and the patient's head will be flexed laterally to the side of the tender point, followed by a shoulder abduction of approximately 90 degrees.
This position will be held for 90 s and then patient position will be passively returned to the initial position.
This will be repeated three times in each session.
Patients will receive two treatment sessions per week for 6 weeks
|
|
Active Comparator: Group-B (Ischemic compression therapy)
Patients will receive Ischemic compression for the Sternocleidomastoid and upper fibers of Trapezius
|
Patients will receive ischemic compression of the trigger points of the upper trapezius and sternocleidomastoid muscle with hold time varying between 30 seconds to 1 minute repeated 3 to 5 times in each session.
Patients will receive two treatment sessions per week for 6 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numeric Pain Rating Scale (NPRS)
Time Frame: 6 weeks
|
It is a standardized self-reporting scale consisting of a horizontal line used to estimate the subjective level of pain intensity.
It is a 11 point numerical scale, corresponding to the degree of pain.
0= no pain, 1-2-3 = mild pain, 4-5-6 = moderate pain, 7-8-9-10 = severe pain.
The patients will be asked to select from that 11 points numerical continuum the number that corresponds to their perceived pain intensity
|
6 weeks
|
|
Headache Disability index (HDI)
Time Frame: 6 weeks
|
This scale is intended to help discover impact of headache.
It contains 27 questions in total.
First two questions are about frequency of headache and remaining 25 regarding impact of headache on daily life of the person.
Each question has three possible answers.
"yes " will score 4 points, " sometimes" will score 2 and "no" will give 0 score.
A total score of 10 - 28 is regarded as an indicator of light disability, the score of 30-48 represents moderate disability, 50-68 expresses severe disability, and 72 or above marks complete disability
|
6 weeks
|
|
Flexion Rotation test (FRT)
Time Frame: 6 weeks
|
Flexion rotation test is used to measure cervical range of motion employing a goniometer.
Impairment in upper cervical spine mobility is associated with cervicogenic headache severity and disability.
Measures of such mobility include the flexion-rotation test (FRT), which requires full cervical flexion and may be influenced by lower cervical spine dysfunction.
|
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ghulam Fatima, PHD*, Riphah International University
Publications and helpful links
General Publications
- Bogduk N, Govind J. Cervicogenic headache: an assessment of the evidence on clinical diagnosis, invasive tests, and treatment. Lancet Neurol. 2009 Oct;8(10):959-68. doi: 10.1016/S1474-4422(09)70209-1.
- Page P. Cervicogenic headaches: an evidence-led approach to clinical management. Int J Sports Phys Ther. 2011 Sep;6(3):254-66.
- Olesen J. International Classification of Headache Disorders. Lancet Neurol. 2018 May;17(5):396-397. doi: 10.1016/S1474-4422(18)30085-1. Epub 2018 Mar 14. No abstract available.
- Knackstedt H, Bansevicius D, Aaseth K, Grande RB, Lundqvist C, Russell MB. Cervicogenic headache in the general population: the Akershus study of chronic headache. Cephalalgia. 2010 Dec;30(12):1468-76. doi: 10.1177/0333102410368442. Epub 2010 May 19.
- Garcia JD, Arnold S, Tetley K, Voight K, Frank RA. Mobilization and Manipulation of the Cervical Spine in Patients with Cervicogenic Headache: Any Scientific Evidence? Front Neurol. 2016 Mar 21;7:40. doi: 10.3389/fneur.2016.00040. eCollection 2016.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- REC/RCR & AHS/24/0152
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervicogenic Headache
-
Meltem UzunCompletedExercise | Therapeutics | Headache, CervicogenicTurkey
-
Alabama Physical Therapy & AcupunctureUniversidad Rey Juan CarlosCompletedCervicogenic HeadachesUnited States
-
Des Moines UniversityCompleted
-
Hungarian University of Sports ScienceCairo UniversityCompleted
-
Foundation University IslamabadRecruiting
-
Cairo UniversityNot yet recruiting
-
University of LahoreCompletedCervicogenic HeadachePakistan
-
Istanbul Medipol University HospitalIstanbul Kent UniversityCompletedCervicogenic Headache | Cervicogenic HeadachesTurkey (Türkiye)
-
Ankara City Hospital BilkentRecruitingCervicogenic Headache | Third Occipital NerveTurkey (Türkiye)
-
Hong Kong Baptist UniversityActive, not recruiting
Clinical Trials on Jones technique
-
Blanca González SanchezCompleted
-
Riphah International UniversityNot yet recruitingCervicogenic HeadachePakistan
-
Cairo UniversityNot yet recruiting
-
King Edward Medical UniversityMayo Hospital LahoreRecruiting
-
Mahidol UniversityCompletedPostoperative Blood LossThailand
-
Universidad Católica San Antonio de MurciaCompletedLow Back Pain | Trigger Point Pain, MyofascialSpain
-
Universidad Católica San Antonio de MurciaCompletedNeck Pain | Trigger Point Pain, MyofascialSpain
-
University of DuhokCompletedChildren, Only | Fracture Distal RadiusIraq
-
University of BolognaRecruitingAbdominal Aortic Aneurysm | Endovascular Aortic RepairItaly
-
Universidad Autonoma de Baja CaliforniaCompletedPost Operative PainMexico